Distinction between serous tumors of low malignant potential and serous carcinomas

ABSTRACT: OBJECTIVES: The molecular pathogenesis of ovarian serous tumors of low malignant potential (S-LMP) is not well understood, although the collective data suggest that they arise through molecular mechanisms distinct from those leading to conventional serous carcinomas (S-Ca). To further examine the molecular differences between these two diseases, we studied the gene expression pattern of ovarian S-LMP and S-Ca using high-density spotted cDNA and tissue microarrays. METHODS: Total RNA from 23 ovarian S-LMP and S-Ca was analyzed on 43,200 spot cDNA microarrays and the differential expression of proteins encoded by differentially expressed genes was validated using tissue microarrays. A clinical history design type is where the organisms clinical history of diagnosis, treatments, e.g. vaccinat

ORGANISM(S): Homo sapiens

SUBMITTER: Matt Van De Rijn 

PROVIDER: E-GEOD-3208 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress